MedPath

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Not Applicable
Completed
Conditions
Ametropia
Interventions
Device: Lens A (comfilcon A lens)
Device: Lens B (lehfilcon A lens)
Registration Number
NCT05166902
Lead Sponsor
Coopervision, Inc.
Brief Summary

To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.

Detailed Description

This study is a prospective, bilateral eye, double-masked, randomized, 1-month cross-over, daily-wear design involving two different FRP lens types. Each lens type will be worn for approximately one month.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
67
Inclusion Criteria
  1. Is at least 18 years of age and no older than 35 years, and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Is willing and able to follow instructions and maintain the appointment schedule;
  4. Self-reports having a full eye examination in the previous two years;
  5. Self-reports spending on most days at least 6 hours cumulative (not necessarily in one single stretch) using digital devices such as a computer, laptop, tablet, e-reader, smartphone;
  6. Has healthy eyes with no health condition or medication that contra-indicate contact lens wear, in the opinion of the investigator;
  7. Anticipates being able to wear the study lenses for at least 8 hours a day, 6 days a week;
  8. Habitually wears soft frequent replacement contact lenses, for the past 3 months minimum (NOTE: The habitual contact lens brand was restricted such that no more than one third were to be Biofinity Energys brand (or their equivalent private label brand name) and no more than one third were to be Alcon brand);
  9. Has refractive astigmatism no higher than -0.75DC in each eye;
  10. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere +6.00 to -6.00D, 0.25D steps).
Exclusion Criteria
  1. Is participating in any concurrent clinical or research study;
  2. Has any known active ocular disease and/or infection that contraindicates contact lens wear;
  3. Has a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable;
  4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  5. Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  7. Has undergone refractive error surgery or intraocular surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Lens A, Then Lens BLens A (comfilcon A lens)Participants will wear lens A for one month and then cross over to wear lens B for one month.
Lens B, Then Lens ALens A (comfilcon A lens)Participants will wear lens B for one month and then cross over to wear lens A for one month.
Lens A, Then Lens BLens B (lehfilcon A lens)Participants will wear lens A for one month and then cross over to wear lens B for one month.
Lens B, Then Lens ALens B (lehfilcon A lens)Participants will wear lens B for one month and then cross over to wear lens A for one month.
Primary Outcome Measures
NameTimeMethod
Subjective Ratings on Lens Handling on RemovalDay 27

Subjective ratings on lens handling on removal will be measured on a scale of 0-10, 0.5 steps (10= Very Easy, 0= Very Difficult)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Spadina Optometry

πŸ‡¨πŸ‡¦

Toronto, Ontario, Canada

Coan Eye Care

πŸ‡ΊπŸ‡Έ

Ocoee, Florida, United States

Nittany Eye Associate

πŸ‡ΊπŸ‡Έ

State College, Pennsylvania, United States

Eyes on Sheppard Clinic

πŸ‡¨πŸ‡¦

Toronto, Ontario, Canada

Β© Copyright 2025. All Rights Reserved by MedPath